ArticleJournal of Korean medical science2018

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib.

Myung Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.